Publication

Type B Aortic Dissection After the Use of Tadalafil

Lameijer, C. M., Tielliu, I. F. J., van Driel, M. F. & Zeebregts, C. J., Feb-2012, In : Annals of thoracic surgery. 93, 2, p. 651-653 3 p.

Research output: Contribution to journalEditorialAcademicpeer-review

A 63-year-old male patient with a type B aortic dissection after the use of tadalafil, a phosphodiesterase type 5 inhibitor, is presented. The possible role of a novel predisposing factor-sexual activity combined with tadalafil-is reviewed. This report and three other cases add a new dimension to the known predisposing factors such as chronic systemic hypertension, hereditary connective tissue diseases-and congenital aortic valve diseases. However, the precise role of phosphodiesterase type 5 inhibitors in the pathophysiology of aortic dissection remains unknown. (Ann Thorac Surg 2012;93:651-3) (C) 2012 by The Society of Thoracic Surgeons

Original languageEnglish
Pages (from-to)651-653
Number of pages3
JournalAnnals of thoracic surgery
Volume93
Issue number2
Publication statusPublished - Feb-2012

    Keywords

  • SILDENAFIL, EXERCISE, PRESSURE

ID: 5488451